Loading
KG
Kindstar Globalgene Technology, Inc. Stock: price and insider trades · Hong Kong
HK·Mcap HK$899.5M
No insider purchase over the last 90 days. The latest, by Huang Shiang, was filed 19 Jan 2023.
Kindstar Globalgene Technology, Inc.: what insiders have been doing
Kindstar Globalgene Technology, Inc. is a listed company. Its insiders report their share dealings to HKEX. The past year has been quiet: not a single insider filing for Kindstar Globalgene Technology, Inc. The previous disclosure was published on 19 January 2023.
Looking back to 2021, when coverage begins, insiders filed 37 purchases and 1 sale.
In the same market, recent insider purchases at Sun Hung Kai Properties Ltd. and Xinyi Glass Holdings Ltd. also feature in our signals. Source: insider filings from HKEX. Past trades are no guide to future returns.
Insider Decl.
40
Thresholds
n/a
Buy Volume
€562,337
37 ops. · all time
Sell Volume
n/a
1 ops. · all time
Since the insiders bought
- -37.8%Entry HK$2.46 · Close at T+365 HK$1.53
- -25.8%Entry HK$2.75 · Close at T+365 HK$2.04
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 19,583 of 26,282 companies
34.8
score / 100
Value38
Quality32
FCF yld4.8%
Earn yld-6.5%
EV/EBITDA16.4x
ROE-1.5%
Gross mgn44%
Net mgn-6.3%
Debt/EBITDA5.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$0.91
Analyst consensus
Income statement
RevenueHK$933.6M
Gross profitHK$410.9M44% margin
EBITDAHK$80M9% margin
Net income-HK$58.7M-4.4% margin
Valuation
P/Book0.3x
Beta0.63
Balance sheet & cash
Market capHK$899.5M
Total debtHK$413.9M
Free Cash FlowHK$43.6M
Debt / Equity15%
Profitability & ownership
ROE-1.5%
ROA-2.4%
% insiders40.9%
% institutions15.8%
Last declaration on 19 January 2023
Declarations40 total
500 shares@ HK$2.550.1% of flowShareXHKGHKEX:DA20230119E00356
Canonical exit: 11 Oct 2022 (T+90)
65,000 shares@ HK$2.487.0% of flowShareXHKGHKEX:DA20220714E00368
Canonical exit: 10 Oct 2022 (T+90)
100,000 shares@ HK$2.45410.7% of flowShareXHKGHKEX:DA20220713E00394
Canonical exit: 9 Oct 2022 (T+90)
4,000 shares@ HK$2.3740.4% of flowShareXHKGHKEX:DA20220711E00227
Canonical exit: 5 Oct 2022 (T+90)
21,500 shares@ HK$2.3122.1% of flowShareXHKGHKEX:DA20220708E00422
Canonical exit: 4 Oct 2022 (T+90)
36,000 shares@ HK$2.2883.5% of flowShareXHKGHKEX:DA20220707E00413
Canonical exit: 3 Oct 2022 (T+90)
31,500 shares@ HK$2.293.0% of flowShareXHKGHKEX:DA20220706E00395
Canonical exit: 2 Oct 2022 (T+90)
37,000 shares@ HK$2.2353.5% of flowShareXHKGHKEX:DA20220705E00258
Canonical exit: 28 Sept 2022 (T+90)
37,500 shares@ HK$2.243.5% of flowShareXHKGHKEX:DA20220704E00180
Canonical exit: 27 Sept 2022 (T+90)
65,500 shares@ HK$2.1926.0% of flowShareXHKGHKEX:DA20220630E00078
Canonical exit: 26 Sept 2022 (T+90)
100,000 shares@ HK$2.2349.3% of flowShareXHKGHKEX:DA20220628E00568
Canonical exit: 25 Sept 2022 (T+90)
45,000 shares@ HK$2.1344.0% of flowShareXHKGHKEX:DA20220622E00061
Canonical exit: 15 Sept 2022 (T+90)
21,500 shares@ HK$2.1491.9% of flowShareXHKGHKEX:DA20220620E00350
Canonical exit: 14 Sept 2022 (T+90)
9,500 shares@ HK$2.1760.9% of flowShareXHKGHKEX:DA20220617E00439
Canonical exit: 13 Sept 2022 (T+90)
11,000 shares@ HK$2.131.0% of flowShareXHKGHKEX:DA20220617E00437
Canonical exit: 12 Sept 2022 (T+90)
22,000 shares@ HK$2.162.0% of flowShareXHKGHKEX:DA20220616E00268
Canonical exit: 11 Sept 2022 (T+90)
18,500 shares@ HK$2.291.7% of flowShareXHKGHKEX:DA20220531E00149
Canonical exit: 25 Aug 2022 (T+90)
14,000 shares@ HK$2.311.3% of flowShareXHKGHKEX:DA20220527E00153
Canonical exit: 24 Aug 2022 (T+90)
89,000 shares@ HK$2.258.2% of flowShareXHKGHKEX:DA20220527E00151
Canonical exit: 23 Aug 2022 (T+90)
27,000 shares@ HK$2.212.4% of flowShareXHKGHKEX:DA20220526E00382
Canonical exit: 22 Aug 2022 (T+90)
13,000 shares@ HK$2.241.2% of flowShareXHKGHKEX:DA20220524E00155
Canonical exit: 18 Aug 2022 (T+90)
12,000 shares@ HK$2.201.1% of flowShareXHKGHKEX:DA20220523E00029
Canonical exit: 17 Aug 2022 (T+90)
99,500 shares@ HK$2.199.1% of flowShareXHKGHKEX:DA20220520E00562
Canonical exit: 16 Aug 2022 (T+90)
60,500 shares@ HK$2.195.5% of flowShareXHKGHKEX:DA20220519E00495
Canonical exit: 15 Aug 2022 (T+90)
17,000 shares@ HK$2.101.5% of flowShareXHKGHKEX:DA20220518E00310
Canonical exit: 14 Aug 2022 (T+90)
25 of 40 declarations
About Kindstar Globalgene Technology, Inc.
Kindstar Globalgene Technology, Inc. is a company specializing in genetic diagnostic services and medical testing. It primarily operates in the Hong Kong market.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations